ranolazine has been researched along with Complications of Diabetes Mellitus in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alexander, KP; Anstrom, KJ; Ben-Yehuda, O; Fanaroff, AC; James, SK; Mark, DB; Ohman, EM; Prather, K; Stone, GW; Weisz, G | 1 |
| Galderisi, M; Mafrici, A | 1 |
| Arora, RR; Patel, PD | 1 |
| Braunwald, E; Chaitman, BR; Karwatowska-Prokopczuk, E; McCabe, CH; McGuire, DK; Morrow, DA; Murphy, SA; Scirica, BM | 1 |
| Sweeney, M | 1 |
1 review(s) available for ranolazine and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
Utility of ranolazine in chronic stable angina patients.
Topics: Acetanilides; Angina Pectoris; Cardiovascular Agents; Chronic Disease; Diabetes Complications; Glycated Hemoglobin; Humans; Piperazines; Ranolazine; Treatment Outcome | 2008 |
2 trial(s) available for ranolazine and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
Ranolazine After Incomplete Percutaneous Coronary Revascularization in Patients With Versus Without Diabetes Mellitus: RIVER-PCI Trial.
Topics: Aged; Angina Pectoris; Cardiovascular Agents; Diabetes Complications; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Ranolazine | 2017 |
Evaluation of the glycometabolic effects of ranolazine in patients with and without diabetes mellitus in the MERLIN-TIMI 36 randomized controlled trial.
Topics: Acetanilides; Acute Coronary Syndrome; Aged; Blood Glucose; Cardiovascular Agents; Diabetes Complications; Diabetes Mellitus; Double-Blind Method; Female; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Hyperglycemia; Male; Metabolic Syndrome; Middle Aged; Piperazines; Prospective Studies; Ranolazine; Recurrence | 2009 |
3 other study(ies) available for ranolazine and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
[Symptomatic coronary heart disease therapy: ranolazine reduces frequency of angina in diabetic patients].
Topics: Acetanilides; Angina Pectoris; Diabetes Complications; Humans; Piperazines; Placebo Effect; Randomized Controlled Trials as Topic; Ranolazine; Sodium Channel Blockers | 2013 |
[The TERISA study].
Topics: Acetanilides; Angina Pectoris; Diabetes Complications; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Humans; Piperazines; Randomized Controlled Trials as Topic; Ranolazine | 2013 |
Effects of very low-fat diets on anginal symptoms.
Topics: Acetanilides; Angina Pectoris; Carnitine; Chemotherapy, Adjuvant; Diabetes Complications; Diabetes Mellitus; Diet, Fat-Restricted; Diet, Vegetarian; Endothelium, Vascular; Enzyme Inhibitors; Fatty Acids; Heart; Humans; Piperazines; Randomized Controlled Trials as Topic; Ranolazine; Treatment Outcome | 2004 |